<DOC>
	<DOCNO>NCT01203072</DOCNO>
	<brief_summary>The objective study ass efficacy , safety dose-response relationship DU-176b compare placebo prevention venous thromboembolism patient elective total knee arthroplasty .</brief_summary>
	<brief_title>A Phase 2b Study DU-176b , Prevention Venous Thromboembolism Patients After Total Knee Arthroplasty</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Edoxaban</mesh_term>
	<criteria>Patients undergo unilateral total knee arthroplasty risk hemorrhage thromboembolic risk weight less 40 kg pregnant , suspect pregnancy , subject want become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>prevention</keyword>
	<keyword>venous thromboembolism</keyword>
	<keyword>edoxaban</keyword>
	<keyword>factor Xa</keyword>
</DOC>